+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Pharmaceutical Industry in the United States 2022 - Product Thumbnail Image

Pharmaceutical Industry in the United States 2022

  • Report
  • September 2022
  • 150 Pages
  • United States
From
Idiopathic Pulmonary Fibrosis (IPF) Market 2025-2029 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis (IPF) Market 2025-2029

  • Report
  • February 2025
  • 218 Pages
  • Global
From
Vaginitis Therapeutics Market Report 2025 - Product Thumbnail Image

Vaginitis Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Pruritus Drugs Market 2024-2028 - Product Thumbnail Image

Pruritus Drugs Market 2024-2028

  • Report
  • October 2024
  • 157 Pages
  • Global
From
Drug Discovery Outsourcing Market Report 2023-2033 - Product Thumbnail Image

Drug Discovery Outsourcing Market Report 2023-2033

  • Report
  • June 2023
  • 389 Pages
  • Global
From
Dermatological Drugs Market 2024-2028 - Product Thumbnail Image

Dermatological Drugs Market 2024-2028

  • Report
  • July 2024
  • 139 Pages
  • Global
From
Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Post-Transplant Lymphoproliferative Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CXCR4 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

CXCR4 Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Hemorrhagic Stroke Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemorrhagic Stroke Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 287 Pages
  • Global
From
Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 387 Pages
  • Global
From
Cardiotonic Agents - Global Strategic Business Report - Product Thumbnail Image

Cardiotonic Agents - Global Strategic Business Report

  • Report
  • October 2025
  • 568 Pages
  • Global
From
Anticoagulant Reversal Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticoagulant Reversal Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 140 Pages
  • Global
From
Long QT Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Long QT Syndrome Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 277 Pages
  • Global
From
Pericarditis Drugs - Global Strategic Business Report - Product Thumbnail Image

Pericarditis Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 289 Pages
  • Global
From
Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • October 2025
  • 94 Pages
  • Global
From
Anti-Ischemic Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Ischemic Agents - Global Strategic Business Report

  • Report
  • October 2025
  • 94 Pages
  • Global
From
Loading Indicator